Osaka General Medical Center   Report issue

Academic/Hospital Phase 4
Founded: Osaka Japan (2006)

Organization Overview

First Clinical Trial
2008
NCT00700375
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

OsakaGeneralMedicalCenter | Osaka General Medical Center

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Heart Failure (Phase 4)

Infarction (Phase 4)

Kidney Diseases (Phase 4)

Kidney Failure, Chronic (Phase 4)

Myocardial Infarction (Phase 4)

Renal Insufficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4